PRESENTATION OF 2 EPITOPES OF THE PRES2 REGION OF HEPATITIS-B VIRUS ON LIVE RECOMBINANT BACTERIA

被引：0
|
作者：
CHARBIT, A
SOBCZAK, E
MICHEL, ML
MOLLA, A
TIOLLAIS, P
HOFNUNG, M
机构：
[1] INST PASTEUR,CNRS,RECOMBINAISON & EXPRESS GENET UNITE 271,F-75724 PARIS 15,FRANCE
[2] INST PASTEUR,INSERM,U163,F-75724 PARIS 15,FRANCE
来源：
JOURNAL OF IMMUNOLOGY | 1987年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1658 / 1664
页数：7
相关论文
共 50 条
  • [21] Mutations in the hepatitis B virus preS2 region and abrogated receptor activity for polymerized human albumin
    Kondo, J
    Shimomura, H
    Fujioka, S
    Iwasaki, Y
    Takagi, S
    Ohnishi, Y
    Tsuji, H
    Sakaguchi, K
    Yamamoto, K
    Tsuji, T
    ACTA MEDICA OKAYAMA, 2002, 56 (04) : 193 - 198
  • [22] EXPRESSION OF THE HEPATITIS-B SURFACE-ANTIGEN GENE CONTAINING THE PRES2 REGION IN SACCHAROMYCES-CEREVISIAE
    YOSHIDA, I
    TAKAMIZAWA, A
    FUJITA, H
    MANABE, S
    OKABE, A
    ACTA MEDICA OKAYAMA, 1991, 45 (01) : 1 - 10
  • [23] Establishment of a Hepatitis B Virus Reporter System Harboring an HiBiT-Tag in the PreS2 Region
    Nakaya, Yuki
    Onomura, Daichi
    Hoshi, Yuji
    Yamagata, Tomoko
    Morita, Hiromi
    Okamoto, Hiroaki
    Murata, Kazumoto
    JOURNAL OF INFECTIOUS DISEASES, 2024, 231 (01): : 204 - 213
  • [24] HETEROGENEITY OF HEPATITIS-B VIRUS SURFACE-ANTIGEN IN SERA OF PATIENTS WITH ACUTE HEPATITIS-B INFECTION IN RELATIVE CONTENT OF THE ANTIGENIC DETERMINANTS A AND PRES2
    GRIGORIEV, VG
    GRIGORIEVA, IM
    ALTSTEIN, AD
    IMMUNOLOGY LETTERS, 1993, 36 (03) : 289 - 294
  • [25] INVITRO IMMUNE-RESPONSES TO HEPATITIS-B SURFACE-ANTIGENS S AND PRES2 DURING ACUTE INFECTION BY HEPATITIS-B VIRUS IN HUMANS
    CUPPS, TR
    HOOFNAGLE, JH
    ELLIS, RW
    MILLER, WJ
    GERIN, JL
    VOLKMAN, DJ
    HAASSMITH, SA
    JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (03): : 412 - 419
  • [26] TEMPORAL EXPRESSION OF PRES2 SEROLOGICAL MARKERS DURING ACUTE HEPATITIS-B INFECTION
    MIMMS, LT
    FLOREANI, M
    TYNER, J
    ROSENLOF, R
    PERRILLO, R
    HEPATOLOGY, 1989, 10 (04) : 576 - 576
  • [27] WEAK IMMUNOGENICITY OF THE PRES2 SEQUENCE AND LACK OF CIRCUMVENTING EFFECT ON THE UNRESPONSIVENESS TO THE HEPATITIS-B VIRUS-VACCINE
    PILLOT, J
    POYNARD, T
    ELIAS, A
    MAILLARD, J
    LAZIZI, Y
    BRANCER, M
    DUBREUIL, P
    BUDKOWSKA, A
    CHAPUT, JC
    VACCINE, 1995, 13 (03) : 289 - 294
  • [28] IMMUNOGENICITY AND SAFETY OF A RECOMBINANT HEPATITIS-B VACCINE PRODUCED IN MAMMALIAN-CELLS AND CONTAINING THE S AND THE PRES2 SEQUENCES
    CORRADI, MP
    TATA, C
    MARCHEGIANO, P
    VILLA, E
    DEPALMA, M
    TRIANNI, G
    FUIANO, L
    ROMPIANESI, P
    SCACCHETTI, T
    ARCHIVES OF VIROLOGY, 1992, : 147 - 153
  • [29] Mutations in hepatitis B virus preS2 region and abrogated polymerized human albumin binding activity.
    Kondo, J
    Shimomura, H
    Nakagawa, H
    Fujio, K
    Fujioka, S
    Miyake, M
    Ikeda, F
    Itoh, M
    Tsuji, H
    Iwasaki, Y
    Tsuji, T
    HEPATOLOGY, 1998, 28 (04) : 480A - 480A
  • [30] DISCRIMINATION OF HEPATITIS-B VIRUS (HBV) SUBTYPES USING MONOCLONAL-ANTIBODIES TO THE PRES1 AND PRES2 DOMAINS OF THE VIRAL ENVELOPE
    MIMMS, LT
    FLOREANI, M
    TYNER, J
    WHITTERS, E
    ROSENLOF, R
    WRAY, L
    GOETZE, A
    SARIN, V
    EBLE, K
    VIROLOGY, 1990, 176 (02) : 604 - 619
12345